sesión 2015 02 19 (caso salupharma, s.a. -objetivos)

VENTAS

PRODUCTO

0

VENTAS

PRODUCTO

1

VENTAS

INDUSTRIA

0

VENTAS

INDUSTRIA

1

MARKET

SHARE 0

MARKET

SHARE 1POSICIN 0 POSICIN 1

%

PRODUCTO

%

INDUSTRIARMSh EVOLUCIN

VENTAS

PRODUCTO

2

%

PRODUCTO

2

MARKET

SHARE 2

HONGUIFN 30,000 15,000 160,000 122,000 18.75 12.30 1 7 -50.00 -23.75 0.56 65.57

DOLFN 2,000 3,000 11,100 14,400 18.02 20.83 2 2 50.00 29.73 0.46 115.62

DESGAFN 1,000 1,850 3,900 5,100 25.64 36.27 1 1 85.00 30.77 2.64 141.48

ACIFN 200 300 810 820 24.69 36.59 2 1 50.00 1.23 1.50 148.15

RESFRIAFN 100 150 170 440 58.82 34.09 1 1 50.00 158.82 1.88 57.92

REDFN 100 75 1,425 1,875 7.02 4.00 5 7 -25.00 31.58 0.13 57.00

SALUPHARMA 33,400 20,375 177,405 144,635 -39.00 -18.47

GUATEMALA UNITED STATES OF AMERICA

http://sites.google.com/site/holoscorp www.andronikos.org

(502) 5204-3908 (1+951) 479-7172

SALUPHARMA

GUATEMALA UNITED STATES OF AMERICA

http://sites.google.com/site/holoscorp www.andronikos.org

(502) 5204-3908 (1+951) 479-7172

REDFN

DESGAFN

DOLFN

HONGUIFN

PRODUCTO ESTRATEGIA OBJETIVO ESPECFICOOBJETIVO

GENERAL

ACIFN

RESFRIAFN